Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4442763
Max Phase: Preclinical
Molecular Formula: C20H19FN6OS
Molecular Weight: 410.48
Molecule Type: Unknown
Associated Items:
ID: ALA4442763
Max Phase: Preclinical
Molecular Formula: C20H19FN6OS
Molecular Weight: 410.48
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(NCc1ccc(F)cn1)c1csc(CCNCc2nc3ccccc3[nH]2)n1
Standard InChI: InChI=1S/C20H19FN6OS/c21-13-5-6-14(23-9-13)10-24-20(28)17-12-29-19(27-17)7-8-22-11-18-25-15-3-1-2-4-16(15)26-18/h1-6,9,12,22H,7-8,10-11H2,(H,24,28)(H,25,26)
Standard InChI Key: CIYKDGMUWCWDAW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 410.48 | Molecular Weight (Monoisotopic): 410.1325 | AlogP: 2.82 | #Rotatable Bonds: 8 |
Polar Surface Area: 95.59 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.49 | CX Basic pKa: 7.90 | CX LogP: 1.78 | CX LogD: 1.16 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.39 | Np Likeness Score: -2.11 |
1. (2018) Novel Ferroportin Inhibitors, |
Source(1):